Torrent Pharmaceuticals Ltd.

₹4,390

-56 (-1.3%)

TORNTPHARM Share Price

Pharmaceuticals & Biotechnology

As on March 13, 2026

SectorHealthcare

IndustryPharmaceuticals & Biotechnology

Basic IndustryPharmaceuticals

Market Cap₹ 1,48,503 Cr

P/E Ratio77.74

Dividend Yield0.15 %

Trendline Performance

We are partnered with TradingView, a global leader in charting and market analysis. Access real-time stock data, explore the powerful Stock Screener , and uncover insights with multiple tools designed for traders.

Unlock Stock of the Month

T&C*

Technicals

Indicators	Value	Signal
5-DMA	4,413.74	Bearish
10-DMA	4,378.34	Bullish
20-DMA	4,329.22	Bullish
50-DMA	4,122.86	Bullish
100-DMA	3,926.24	Bullish
200-DMA	3,699.25	Bullish

Historical Performance

1 Year

43.6%

3 Years

191%

5 Years

256.7%

10 Years

581.7%

Shareholding Pattern

Values Analysis

Loading chart...

Profit & Loss

Below figures are in Rs. Crores

Particulars	Mar-2025	Mar-2024	Mar-2023	Mar-2022	Mar-2021
Net Sales	1,15,161	1,07,278	96,202	85,080	80,046
Total Expenditure	78,117	73,642	67,962	60,768	55,245
Other Income	399	620	632	1,966	569
Operating Profit	37,443	34,256	28,872	26,278	25,370
Interest	2,523	3,536	3,334	2,551	3,529
Depreciation	7,949	8,083	7,066	6,622	6,578
Profit Before Tax	26,728	23,521	18,472	12,259	15,263
Consolidated Net Profit	19,112	16,564	12,452	7,772	12,519
Adjusted EPS	56	49	37	23	37

Compounded Sales Growth

10 Years:19.9

5 Years:7.7

3 Years:6.2

TTM:1.4

Compounded Profit Growth

10 Years:20.5

5 Years:13.3

3 Years:19.7

TTM:2.9

Stock Price CAGR

10 Years:21.2

5 Years:29

3 Years:42.4

TTM:43.7

Return on Equity

10 Years:51.2

5 Years:37

3 Years:36.8

last year:56.5

Quarterly Results

Below figures are in Rs. Crores

Particulars	Sep-2024	Dec-2024	Mar-2025	Jul-2025	Sep-2025
Sales	1,70,754	1,35,936	1,28,552	1,22,189	1,05,161
Expenses	63,042	56,557	52,457	45,459	34,856
Operating Profit	1,07,712	79,379	76,096	76,730	70,304
OPM %	63%	58%	59%	63%	67%
Other Income	33,912	31,759	27,333	24,879	18,947
Interest	77,780	58,584	59,248	62,137	53,713
Depreciation	2,345	1,681	1,385	1,277	1,221
Profit Before Tax	61,498	50,873	42,796	38,195	34,318
Tax %	25%	25%	26%	29%	35%
Net Profit	46,149	38,151	31,857	27,296	22,446
EPS in Rs	83	69	58	50	42

Balance Sheet

Below figures are in Rs. Crores

Particulars	Mar-2025	Mar-2024	Mar-2023	Mar-2022	Mar-2021
Share Capital	1,692	1,692	1,692	846	846
Total Reserves	74,215	66,869	60,288	58,683	57,525
Long-Term Borrowings	---	---	---	---	---
Total Non-Current Liabilities	20,877	22,241	28,228	22,381	29,242
Other Current Liabilities	11,435	11,302	15,784	13,651	16,354
Short Term Borrowings	12,500	16,377	17,651	9,230	7,044
Total Liabilities	1,43,956	1,45,055	1,44,682	1,26,062	1,36,530
Capital Work in Progress	3,673	2,808	6,882	5,443	7,439
Long Term Loans & Advances	2,943	3,493	1,810	1,666	968
Currents Investments	1,122	1,410	1,561	1,840	1,391
Short Term Loans and Advances	1,996	1,800	1,658	1,512	634
Total Current Assets	56,226	56,115	53,137	51,650	55,215
Total Assets	1,43,956	1,45,055	1,44,682	1,26,062	1,36,530
Adjusted Book Value	224	203	183	176	172

Positive

(80 to 100)

Neutral

(60 to 79)

Negative

(0 to 59)

The stock has a high PE of 77.74, indicating expensive valuation or elevated growth expectations.
Over the last three years, the stock delivered a strong 3-year price CAGR of 42.4%, indicating sustained price appreciation.
The stock carries a low beta of 0.6, suggesting lower volatility than the broader market.
In the last financial year, the company reported an EBITDA of ₹37443 million, reflecting positive operating performance.
In the previous financial year, the company generated revenue of ₹115161 million, indicating a large and established business.

Investment Calculator

Investment Amount:

₹

Investment Amount: ₹ 1000000

Current Value: ₹ 1431669.6

No. of Shares: 326 (Approx)

Performance:43.2%

P/L: ₹431669.6

NIFTY Performance: 3.4%

1 day Top Gainers